Accelerated Prone Position Ventilation of Patients With COVID-19 — PROVENT-COVID  

COVID-19 Clinical Trial

Official title: Accelerated Prone Position Ventilation of Patients With COVID-19

Status Withdrawn

Clinical Trial Summary

Prone position ventilation is frequently used in the ICU to treat severe hypoxemia in patients with COVID-19 associated acute respiratory distress syndrome (ARDS). The aim of the PROVENT-COVID study is to assess whether applying prone position ventilation immediately after intubation reduces the duration of mechanical ventilation compared to prone position ventilation according to standard criteria for prone position.

Clinical Trial Description

In patients with COVID-19 the incidence of ARDS is 15% and the all-cause mortality 4%. No treatment has been shown to improve the outcome of these patients. Mechanical ventilation in the prone position decreases mortality with around 50% when applied to patients with severe respiratory failure. Applying prone position earlier in patients with COVID-19 could have several benefits, but may also carry significant side-effects and an increased workload for the health-care personnel. It is urgently needed to assess whether this potential life-saving intervention is effective. The aim of the PROVENT-COVID is to determine whether prone position ventilation, initiated immediately after intubation, lead to more days alive without respiratory support compared to prone position initiated according to standard indication in patients with COVID-19 associated respiratory failure. ;

Related Conditions & MeSH terms

• COVID-19

• NCT number: NCT04384900
• Study type: Interventional
• Source: Nordsjaellands Hospital
• Status: Withdrawn
• Phase: N/A
• Start date: May 11, 2020
• Completion date: May 25, 2021